summa up semaglutide Injection | Starts at $149/mo summa up semaglutide Weekly improves

Floating particles

The Lancet, 394(10192), 39-50

How It Works Activates both GLP-1 and GIP receptors for a broader metabolic impact Reduces appetite and increases satiety through two hormonal pathways Enhances insulin sensitivity more aggressively than GLP-1 alone Supports reduction of visceral fat the deep abdominal fat most strongly associated with metabolic disease Improves blood sugar regulation through a dual insulin-stimulating mechanism Clinical Results In the SURMOUNT-1 trial, Tirzepatide produced average weight loss of up to 20% of body weight outperforming Semaglutide in head-to-head comparisons

88 Mann JFE, Fonseca VA, Poulter NR, Raz I, Idorn T, Rasmussen S, et al